Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Expands Dx Business in China, India with Two Acquisitions

NEW YORK (GenomeWeb News) – PerkinElmer has acquired two separate companies, one in China and one in India, in a bid to expand its diagnostics and genetic screening businesses.

The firm said that it has completed its acquisition of SYM-BIO Lifescience, a Shanghai, China-based diagnostics firm for around $63.7 million in cash. SYM-BIO supplied Chinese hospitals with infectious disease diagnostic products. PerkinElmer said that the acquisition doubles its access to hospitals in China, offering the firm a larger base to expand its prenatal and newborn screening business.

The deal also provides PerkinElmer with "substantial" manufacturing plant capacity in Shanghai and the surrounding area.

PerkinElmer also announced that it has acquired the genetic screening business of Surendra Genetic Labs, a lab in Chennai, India, that provides fetal, maternal, and newborn screening.

The firm did not disclose the financial terms of that pact.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.